/Sponsor / Executive Profile

Todd Wider

Executive

Aggregate Capital Deployment Matrix

Active/Searching: $130M (25.5%)

Professional Biography

Dr. Todd Wider is a distinguished plastic and reconstructive surgeon with a specialized focus on cancer surgery. He serves as the Executive Chairman and Chief Medical Officer of Emendo Biotherapeutics, where he plays a pivotal role in advancing innovative therapeutic solutions. In addition to his leadership at Emendo Biotherapeutics, Dr. Wider is an active, honorary member of the medical staff at Mount Sinai Hospital in New York, contributing his expertise to the medical community. He also holds the position of Director at ARYA, further demonstrating his commitment to the intersection of medicine and business. Dr. Wider's extensive experience and leadership in both clinical and corporate settings underscore his significant contributions to the fields of medicine and biotechnology.

Total Capital Deployed

$510,000,000

Active / Searching Capital:
$130,000,000

Transaction Volume

4 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

25.0%

Professional Network Intelligence

Frequent Underwriters

Frequent Associates

Top Sectors

  • Biotechnology1 Deals
  • life sciences1 Deals
  • Biopharmaceutical1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
ARYE
ARYA Sciences Acquisition Corp V
searching
130.0M
$10.00
-Jun 2021--GeneralJefferies LLC
ARYD
ARYA Sciences Acquisition Corp IV
closed
130.0M
$10.00
-Feb 2021Done
175.0M
BiotechnologyGoldman Sachs & Co., LLC
NAUT
ARYA Sciences Acquisition Corp III
closed
125.0M
$10.00
-Jul 2020Done
900.0M
life sciencesJefferies LLC
CERE
ARYA Sciences Acquisition Corp II
closed
125.0M
$10.00
1/3May 2020Done
780.0M
BiopharmaceuticalJefferies LLC